Y. Kim

Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial

S. Han, S. Bae, S. Paik, 2018 .

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

D. Heo, B. Keam, C. Ock, 2019, Annals of Oncology.

Efficacy of reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer (CRC)

Jae Hyun Kim, D. Heo, D. Oh, 2005 .

71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results

D. Nuyten, R. Ferris, R. Mehra, 2020 .

720TiP Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma

G. Sonpavde, R. Jain, M. Chatwal, 2021, Annals of Oncology.